484 related articles for article (PubMed ID: 8780380)
1. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
[TBL] [Abstract][Full Text] [Related]
3. Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes.
Starz H; Haas CJ; Schulz GM; Balda BR
Mod Pathol; 2003 Sep; 16(9):920-9. PubMed ID: 13679456
[TBL] [Abstract][Full Text] [Related]
4. Patterns of recurrence in patients with melanoma and histologically negative but RT-PCR-positive sentinel lymph nodes.
Goydos JS; Patel KN; Shih WJ; Lu SE; Yudd AP; Kempf JS; Bancila E; Germino FJ
J Am Coll Surg; 2003 Feb; 196(2):196-204; discussion 204-5. PubMed ID: 12595045
[TBL] [Abstract][Full Text] [Related]
5. [The detection of melanoma metastases in sentinel nodes by polymerase chain reaction].
Poelman M; van der Velde-Zimmermann D; van Doorn LJ; Quint WG; van Krimpen C; de Graaf PW
Ned Tijdschr Geneeskd; 1998 Apr; 142(16):905-8. PubMed ID: 9623187
[TBL] [Abstract][Full Text] [Related]
6. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
7. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
8. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
9. Additional reverse transcription-polymerase chain reaction of peripheral slices is not superior to analysis of the central slice in sentinel lymph nodes from melanoma patients.
Blaheta HJ; Roeger S; Sotlar K; Schittek B; Breuninger H; Bueltmann B; Garbe C
Br J Dermatol; 2004 Mar; 150(3):477-83. PubMed ID: 15030330
[TBL] [Abstract][Full Text] [Related]
10. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.
Abrahamsen HN; Sorensen BS; Nexo E; Hamilton-Dutoit SJ; Larsen J; Steiniche T
Clin Cancer Res; 2005 Feb; 11(4):1425-33. PubMed ID: 15746042
[TBL] [Abstract][Full Text] [Related]
11. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
[TBL] [Abstract][Full Text] [Related]
12. [Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma].
Tessier MH; Denis MG; Lustenberger P; Dreno B
Ann Dermatol Venereol; 1997; 124(9):607-11. PubMed ID: 9739921
[TBL] [Abstract][Full Text] [Related]
13. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
[TBL] [Abstract][Full Text] [Related]
14. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
Kammula US; Ghossein R; Bhattacharya S; Coit DG
J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
[TBL] [Abstract][Full Text] [Related]
15. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
[TBL] [Abstract][Full Text] [Related]
16. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
Davids V; Kidson SH; Hanekom GS
Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
[TBL] [Abstract][Full Text] [Related]
17. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy and melanoma biology.
Essner R
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
[TBL] [Abstract][Full Text] [Related]
19. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
[TBL] [Abstract][Full Text] [Related]
20. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]